Literature DB >> 27653476

Identification of HIV-1-Based Virus-like Particles by Multifrequency Atomic Force Microscopy.

Irene González-Domínguez1, Sonia Gutiérrez-Granados2, Laura Cervera2, Francesc Gòdia2, Neus Domingo3.   

Abstract

Virus-like particles (VLPs) have become a promising platform for vaccine production. VLPs are formed by structural viral proteins that inherently self-assemble when expressed in a host cell. They represent a highly immunogenic and safe vaccine platform, due to the absence of the viral genome and its high protein density. One of the most important parameters in vaccine production is the quality of the product. A related bottleneck in VLP-based products is the presence of cellular vesicles as a major contaminant in the preparations, which will require the set up of techniques allowing for specific discrimination of VLPs from host vesicular bodies. In this work novel, to our knowledge, multifrequency (MF) atomic force microscopy (AFM) has permitted full structural nanophysical characterization by its access to the virus capsid of the HIV-based VLPs. The assessment of these particles by advanced amplitude modulation-frequency modulation (AM-FM) viscoelastic mapping mode has enhanced the imaging resolution of their nanomechanical properties, opening a new window for the study of the biophysical attributes of VLPs. Finally, the identification and differentiation of HIV-based VLPs from cellular vesicles has been performed under ambient conditions, providing, to our knowledge, novel methodology for the monitoring and quality control of VLPs.
Copyright © 2016 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27653476      PMCID: PMC5034347          DOI: 10.1016/j.bpj.2016.07.046

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  19 in total

Review 1.  Virus-like particles as immunogens.

Authors:  Rob Noad; Polly Roy
Journal:  Trends Microbiol       Date:  2003-09       Impact factor: 17.079

2.  Development and validation of a quantitation assay for fluorescently tagged HIV-1 virus-like particles.

Authors:  Sonia Gutiérrez-Granados; Laura Cervera; Francesc Gòdia; Jorge Carrillo; María Mercedes Segura
Journal:  J Virol Methods       Date:  2013-05-24       Impact factor: 2.014

Review 3.  Virus Like Particles as Immunogens and Universal Nanocarriers.

Authors:  Antonina Naskalska; Krzysztof Pyrć
Journal:  Pol J Microbiol       Date:  2015

4.  Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium.

Authors:  Laura Cervera; Sonia Gutiérrez-Granados; Marta Martínez; Julià Blanco; Francesc Gòdia; María Mercedes Segura
Journal:  J Biotechnol       Date:  2013-05-17       Impact factor: 3.307

5.  Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.

Authors:  J W Bess; R J Gorelick; W J Bosche; L E Henderson; L O Arthur
Journal:  Virology       Date:  1997-03-31       Impact factor: 3.616

Review 6.  Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.

Authors:  Johnny C Akers; David Gonda; Ryan Kim; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2013-03-02       Impact factor: 4.130

7.  Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes.

Authors:  Y G Kuznetsov; J G Victoria; W E Robinson; A McPherson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

Authors:  Christine M Thompson; Emma Petiot; Alaka Mullick; Marc G Aucoin; Olivier Henry; Amine A Kamen
Journal:  BMC Biotechnol       Date:  2015-05-16       Impact factor: 2.563

Review 9.  Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

Authors:  Natasha Kushnir; Stephen J Streatfield; Vidadi Yusibov
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

10.  RNA control of HIV-1 particle size polydispersity.

Authors:  Cendrine Faivre-Moskalenko; Julien Bernaud; Audrey Thomas; Kevin Tartour; Yvonne Beck; Maksym Iazykov; John Danial; Morgane Lourdin; Delphine Muriaux; Martin Castelnovo
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

View more
  5 in total

Review 1.  Algal Viruses: The (Atomic) Shape of Things to Come.

Authors:  Christopher T Evans; Oliver Payton; Loren Picco; Michael J Allen
Journal:  Viruses       Date:  2018-09-12       Impact factor: 5.048

Review 2.  Atomic Force Microscopy on Biological Materials Related to Pathological Conditions.

Authors:  Andreas Stylianou; Stylianos-Vasileios Kontomaris; Colin Grant; Eleni Alexandratou
Journal:  Scanning       Date:  2019-05-12       Impact factor: 1.932

3.  At-line multi-angle light scattering detector for faster process development in enveloped virus-like particle purification.

Authors:  Patricia Pereira Aguilar; Irene González-Domínguez; Tobias Amadeus Schneider; Francesc Gòdia; Laura Cervera; Alois Jungbauer
Journal:  J Sep Sci       Date:  2019-06-19       Impact factor: 3.614

4.  Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study.

Authors:  Irene González-Domínguez; Eduard Puente-Massaguer; Laura Cervera; Francesc Gòdia
Journal:  Viruses       Date:  2020-02-17       Impact factor: 5.048

5.  Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus.

Authors:  Diego Fontana; Ernesto Garay; Laura Cervera; Ricardo Kratje; Claudio Prieto; Francesc Gòdia
Journal:  Vaccines (Basel)       Date:  2021-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.